BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Oct 16, 2025

Lobbying activity 2

Pharmacy

issues related to pharmaceutical manufacturing Tax and trade policy affecting the pharmaceutical industry

Trade (domestic/foreign)

Companys expansion of its domestic footprint.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.